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BRIEF DEFINITIVE REPORT
        CD4  +   T cells are essential for adaptive immune 
responses to pathogens and vaccines. Relatively 
constant numbers of naive CD4  +   T cells are 
maintained throughout life by both the thymic 
output of CD4  +   recent thymic emigrants (RTEs) 
and by homeostatic proliferation of existing 
peripheral naive T cells, which replace those 
cells lost by death or conversion to memory/
eff  ector cells (  1  –  3  ). The relative contribution of 
thymic output and homeostatic proliferation to 
the composition of the human naive CD4  +   T 
cell pool throughout aging has been diffi   cult to 
determine precisely. 
  Frequencies of human CD4  +   RTEs have 
been inferred by PCR assays of populations of 
cells for their content of signal joint TCR gene 
excision circles (sjTRECs), which are circular 
DNA products of intrathymic V(D)J recombi-
nation (  4  ). However, using sjTREC content to 
study RTE abundance and biology has impor-
tant disadvantages. First, homeostatic prolifer-
ation results in increased sjTREC loss from 
the naive peripheral T cell compartment (  4, 5  ). 
Second, sjTREC content is not a highly dy-
namic measurement of thymic output, as is in-
dicated by its stability for months after complete 
thymectomy (  3  ). Third, PCR analysis of sjTREC 
content precludes any type of functional analy-
sis of viable CD4  +   RTEs at the single-cell level. 
Although other approaches allow direct in vivo 
labeling of RTEs in humans, such as with   2  H  2  O 
(  6  ), they also do not allow a facile determina-
tion of RTE phenotype and function. Thus, 
identifying an endogenous surface marker for 
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  CD4  +   recent thymic emigrants (RTEs) comprise a clinically and immunologically important 
T cell population that indicates thymic output and that is essential for maintaining a diverse 
          –  T cell receptor (TCR) repertoire of the naive CD4  +   T cell compartment. However, their 
frequency and function are poorly understood because no known surface markers distin-
guish them from older non-RTE naive CD4  +   T cells. We demonstrate that protein tyrosine 
kinase 7 (PTK7) is a novel marker for human CD4  +   RTEs. Consistent with their recent 
thymic origin, human PTK7  +   RTEs contained higher levels of signal joint TCR gene excision 
circles and were more responsive to interleukin (IL)-7 compared with PTK7        naive CD4  +   
T cells, and rapidly decreased after complete thymectomy. Importantly, CD4  +   RTEs prolifer-
ated less and produced less IL-2 and interferon-     than PTK7        naive CD4  +   T cells after         -
TCR/CD3 and CD28 engagement. This immaturity in CD4  +   RTE effector function may 
contribute to the reduced CD4  +   T cell immunity observed in contexts in which CD4  +   RTEs 
predominate, such as in the fetus and neonate or after immune reconstitution. The ability 
to identify viable CD4  +   RTEs by PTK7 staining should be useful for monitoring thymic 
output in both healthy individuals and in patients with genetic or acquired CD4  +   T cell 
immunodefi  ciencies. 
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fi  ed protein tyrosine kinase 7 (PTK7) as a surface marker for 
human CD4  +   RTEs that allows enumeration of their fre-
quency and analysis of their function. 
    RESULTS AND DISCUSSION   
  Identifi  cation of PTK7 as a putative CD4  +   RTE marker 
  To identify surface markers on human CD4  +   RTEs, we com-
pared the gene expression profi  les of postnatal mature CD4  + 
CD8        thymocytes and circulating neonatal and adult naive 
CD4  +   T cells. We reasoned that neonatal naive CD4  +   T cells 
RTEs would overcome the disadvantages of sjTREC assays 
or of in vivo labeling with stable isotopes. 
  An understanding of RTE biology in humans is also of 
clinical interest, as studies in rodents have suggested impaired 
RTE function (  7, 8  ). If this immaturity also applies to human 
RTEs, this could limit T cell eff  ector function when RTEs 
likely predominate in the naive T cell compartment, such as 
in the neonate (  9  ) and in older individuals undergoing im-
mune reconstitution, e.g., after highly active antiretroviral 
therapy for HIV infection (  2  ). In this paper, we have identi-
    Figure 1.         sjTREC levels and PTK7 expression decrease with T cell maturation.   (A and B) sjTREC content (A) and PTK7 mRNA expression (B) of 
CD4  + CD8       thymocytes, neonatal CD45RA  high   CD4 +   T cells, and adult naive (CD45RA  high  ) and memory (CD45RA  low )  CD4 +   T cells. K562 cells, which lack 
sjTRECs, were a negative control (sjTREC content and PTK7 mRNA are indicated as mean   ±   SD of two to three donors for each cell type per experiment, 
with results representative of two independent experiments). (C) PTK7 staining of a human PTK7-EGFP  –  transfected CHO cell line (representative result of 
four experiments). (D and E) Jurkat cells (D; representative result of three independent experiments) and human CD4      CD8     ,  CD4 + CD8 + ,  CD4 + CD8     ,  and 
CD4      CD8 +   thymocyte subsets (E, representative result from one of six donors) after PTK7 surface staining (solid line) and isotype control antibody stain-
ing (dashed line). Error bars show the mean   ±   SD.     JEM VOL. 206, February 16, 2009  277
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naive CD4  +   T cells (  Fig. 2 B  ) and the absolute number of 
PTK7  +   naive CD4  +   T cells (Fig. S2, available at http://www
.jem.org/cgi/content/full/jem.20080996/DC1) progressively 
and signifi  cantly decreased with age. This decline appeared to 
be biphasic, with a more rapid phase in early childhood, fol-
lowed by a subsequent slower but progressive decrease with 
aging, and is similar to the pattern of exponential rather than 
linear decay of RTEs with aging reported in nonhuman ver-
tebrates, including rodents (  8, 17  ) and birds (  18  ). These fi  nd-
ings are consistent with the possibility that PTK7  +   naive 
CD4  +   T cells represent RTEs, as thymic cellularity and, likely, 
RTE production also peak in early childhood followed by a 
progressive decline with aging (  19  ). 
  In contrast to the results for thymocytes and naive CD4  +   
T cells, neither PTK7 transcripts (  Fig. 1 B  ) nor surface 
PTK7 ( Fig. 2 A ) were detectable in adult memory CD45RA  low 
(CD45RO  high  ) CD4  +   T cells (  16  ). This suggests that PTK7 
surface protein was lost during postthymic conversion of na-
ive CD4  +   T cells into memory cells. We did not detect in-
ducible expression of PTK7 by PTK7        naive CD4  +   T cells 
after in vitro stimulation with CD3 and CD28 mAbs (un-
published data), indicating that this protein was not up-regu-
lated by T cell activation. PTK7  +   and PTK7        naive CD4  +   
T cells had similar surface levels of         -TCR, CD3, CD5, 
CD28, CD38, CD62-L, and IL-7R     (  Fig. 2 C  ) and diversity 
of the         -TCR repertoire (Fig. S3, available at http://www
.jem.org/cgi/content/full/jem.20080996/DC1). These fi  nd-
ings are also consistent with the PTK7  +   subset representing 
an RTE precursor of PTK7        naive CD4  +   T cells. PTK7 ex-
pression was not detected on circulating human adult CD8  +   
T cells, including the reported CD103  +  CD8  +   RTE subset 
(  20  ), CD4  +  CD25  +  FoxP3  +   regulatory T cells,         -TCR  +   T 
cells, B cells, or NK cells (Fig. S4 and not depicted). 
  Immunological phenotype of circulating PTK7  +   CD4  +   RTEs 
and their postthymic maturation 
  Next, we determined whether these putative PTK7  +   CD4  +   
RTEs exhibited the expected pattern of expression of mark-
ers characteristic for naive CD4  +   T cells. For example, most 
adult circulating naive CD4  +   T cells are CD31  +  , but a CD31        
subset has lower sjTREC content and less         -TCR diversity 
than the CD31  +   fraction and may be generated by foreign 
antigen-independent homeostatic proliferation (  21, 22  ). We 
found that adult PTK7  +   naive CD4  +   T cells were uniformly 
CD31  +  , which is consistent with this population representing 
a precursor of the CD31        cell subset (  Fig. 3 A  ).   As sjTRECs 
are diluted in peripheral T cells by postthymic mitosis, such 
as homeostatic or activation-induced proliferation (  3  ), we 
predicted that if PTK7  +   CD4  +   T cells are bona fi  de RTEs, 
then they should, like CD31  +   naive CD4  +   T cells, have a 
higher sjTREC content compared with the CD31        naive 
CD4  +   T cells that have undergone homeostatic proliferation 
(  21  ). We found that the PTK7  +  CD31  +   putative RTEs con-
tained high levels of sjTRECs (  Fig. 3 B  ), and the PTK7      
CD31        cells had extremely low levels of sjTRECs, which is 
similar to those of memory CD4  +   T cells (  Fig. 1 A  ). Interestingly, 
were enriched in RTEs compared with adult naive CD4  +   T 
cells, as they contained higher levels of sjTRECs than adult na-
ive CD4  +   T cells (  Fig. 1 A  ).   We also hypothesized that periph-
eral CD4  +   RTEs, but not adult naive CD4  +   T cells, continued 
to express a subset of genes expressed by mature CD4  +  CD8        
thymocytes because CD4  +   RTEs have recently completed thy-
mocyte diff  erentiation (  1  ). To test this hypothesis, we generated 
a complementary DNA (cDNA) microarray of     2,500 targets 
in which the transcript abundance of these three T cell popula-
tions was compared (unpublished data). Using quantitative real-
time PCR, we confi  rmed that transcripts for PTK7, a member 
of the receptor tyrosine kinase family (  10  –  12  ), were expressed at 
higher levels by CD4  +  CD8        thymocytes and neonatal CD4  +   T 
cells compared with adult naive CD4  +   T cells (  Fig. 1 B  ). 
  To confi  rm these fi  ndings, we fi  rst established that a rab-
bit anti  –  mouse PTK7 antibody (  13  ) specifi  cally stained hu-
man PTK7 on the cell surface using fl  ow cytometry. This 
specifi  city was verifi  ed by analysis of a human PTK7-EGFP 
cDNA-transfected Chinese hamster ovary (CHO) cell line 
and Jurkat CD4  +  CD8        T-lineage tumor cells, which ex-
press high levels of PTK7 messenger RNA (mRNA;   Fig. 1, 
C and D  ). The specifi   city of the antibody was also vali-
dated using a mouse PTK7-EGFP cDNA-transfected CHO 
cell line, mouse fetal (E17)   PTK7  +/+     and   PTK7      /        thy-
mocytes (  13  ), and mouse EL-4 thymoma cells, which lack 
PTK7 mRNA (Fig. S1, available at http://www.jem.org/
cgi/content/full/jem.20080996/DC1). 
  Next, we tested whether human thymocytes also express 
endogenous surface PTK7. The highest expression was ob-
served on the least mature triple-negative (CD3       CD4       CD8       ) 
thymocyte subset (  14  ) and their immediate derivatives, the 
immature single-positive (CD3       CD4  +  CD8       ) subset (  15  ) 
(  Fig. 1 E  ). PTK7 surface expression progressively decreased 
as thymocytes subsequently transited from the double-positive 
(CD4  +  CD8  +  ) to the most mature single-positive (CD3  high 
CD4  +  CD8        or CD3  high  CD4       CD8  +  ) stage of development 
(  1  ). Mouse thymocytes, like human thymocytes, also exhib-
ited a progressive decrease in PTK7 expression with matura-
tion (Fig. S1). 
  Age-dependent frequency of PTK7-expressing peripheral 
naive CD4  +   T cells 
  If PTK7 represents a marker for human CD4  +   RTEs, then a 
fraction of peripheral CD4  +   T cells should continue to ex-
press it after their export from the thymus. Indeed, we ob-
served a distinct PTK7  +   subset of     10% of antigenically 
naive CD4  +   T cells from adult peripheral blood, as defi  ned 
by their CD45RA  high  CD45RO  low   surface phenotype (  16  ) 
(  Fig. 2 A  ).   As predicted by earlier results of PTK7 mRNA 
expression (  Fig. 1 B  ), the neonatal naive CD4  +   T cell popu-
lation consistently contained a higher percentage of PTK7  +   
cells than the analogous adult population (  Fig. 2 A  ) and a 
higher amount of protein per cell, based on mean fl  uores-
cence intensity values (not depicted). An examination of 22 
diff  erent healthy donors ranging in age between 1 mo and 61 
yr demonstrated that the frequency of PTK7  +   cells among 278 HUMAN CD4  +   RTES IDENTIFIED BY PTK7   | Haines et al. 
    Figure 2.         PTK7 is expressed on a subset of circulating naive CD4  +   T cells that decreases with age and that has a surface phenotype similar 
to PTK7        naive cells.   (A) PTK7 staining (solid line) and isotype staining (dashed line) of circulating naive CD4  +   T cells from a term gestation neonate, a 
4-yr-old child, and an adult, or of adult memory CD4  +   T cells. (B) Frequency of circulating PTK7  +   naive  CD4 +   T cells from donors of various ages (1 mo  –  61 
yr;   n   = 22). A two-phase exponential decay curve (plotted using Prism software [GraphPad Software, Inc.]) was fi  tted and is presented for graphical pur-
poses only. The correlation between age and the frequency of PTK7  +   naive  CD4 +   T cells was signifi  cant (Spearman  ’  s r-value =     0.810; P   <   0.0001; 95% CI 
of     0.920 to     0.581). (C) Surface expression of PTK7 versus the indicated T cell markers by CD4  +   T cells (representative result of three donors).     JEM VOL. 206, February 16, 2009  279
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    Figure 3.         Circulating PTK7  +   naive CD4  +   T cells are uniformly CD31  +  , contain higher sjTREC levels than CD31  +   or CD31        naive CD4  +   T cells 
lacking PTK7, and persistently decline after thymectomy.   (A) CD31 and PTK7 surface expression by circulating adult CD4  +   T cells of the CD45RA  +  
(naive) and CD45RA        (memory) subsets (representative result of four donors). (B) sjTREC content of the PTK7  + CD31 + ,  PTK7     CD31 +  , and PTK7      CD31       sub-
sets of adult naive CD4  +   T cells purifi  ed by FACS (mean   ±   SD of   n   = 3 donors per experiment, with results representative of three independent experi-
ments). The sjTREC content of PTK7  + CD31 +   naive  CD4 +   T cells was arbitrarily set as 100 for each donor. *, P   <   0.0002 by the two-tailed paired Student  ’  s 
  t   test after Bonferroni correction for two comparisons. The bottom graph shows the ratio of sjTREC content of PTK7  + CD31 +   naive  CD4 +   T cells to that of 
PTK7      CD31 +   naive CD4  +   T cells for eight individuals varying in age (Spearman  ’  s r-value = 0.0; P   >   0.05). (C) Left panels show circulating PTK7  + CD45RA +  
naive CD4  +   T cells obtained before and at two time points after thymectomy from myasthenia gravis (MG) patients who were 2 and 14 yr of age (isotype 
staining, dashed line). A 5-yr-old healthy control donor was analyzed twice at a 12-wk interval. Right panels show the concentration of PTK7  +   CD4 +   RTEs, 
PTK7        naive CD4  +   T cells, and total naive CD4  +   T  cells.   280 HUMAN CD4  +   RTES IDENTIFIED BY PTK7   | Haines et al. 
After 7 d of culture, surface CD31 levels were either un-
changed or only slightly diminished, which is similar to the 
pattern previously described for naive CD4  +   T cells overall 
(  22  ). In contrast, surface PTK7 levels expressed by the RTEs 
substantially and progressively declined with each round of 
mitosis (Fig. S5, available at http://www.jem.org/cgi/content/
full/jem.20080996/DC1). These results support a precursor  –
  product relationship in which PTK7  +   CD4  +   RTEs undergo 
proliferation by a mechanism independent of         -TCR/CD3 
engagement and convert to a PTK7        cell population with 
lower sjTREC content while retaining a CD31  high   naive sur-
face phenotype. 
  Immunological function of PTK7  +   CD4  +   RTEs 
  As previous studies have shown that mouse CD4  +   RTEs do 
not fully respond to         -TCR/CD3 stimulation (  8, 24  ), we 
next determined if human CD4  +   RTEs also had functional 
limitations. FACS-purifi  ed human PTK7  +   CD4  +   RTEs acti-
vated using a combination of CD3 and CD28 mAbs coupled 
to beads (    CD3/    CD28 beads) had substantially less incor-
poration of   3  H-thymidine, reduced mitosis in a CFSE assay 
(  25  ), and decreased blastogenesis compared with their PTK7        
naive CD4  +   T cell counterparts (  Fig. 4, A and B  ).   Reduced 
mitosis using the CFSE assay was also observed with 0.03 and 
0.01 beads/cell at both 48 and 72 h (unpublished data). To 
rule out the possibility that the PTK7 antibody staining used to 
purify the cells might inhibit their function, we isolated neonatal 
naive CD4  +   T cells, the majority of which express high levels 
of PTK7 (  Fig. 2 A  ). We compared their proliferative responses 
after either staining with PTK7 antibody or an isotype-matched 
control antibody followed by staining with a secondary fl  uo-
rochrome antibody before     CD3/    CD28 bead stimulation 
and found no inhibition of their proliferation (  Fig. 4 C  ). In 
addition, no signifi  cant diff  erences in apoptosis were observed 
between activated PTK7  +   CD4  +   RTEs and PTK7        naive 
CD4  +   T cells that could account for the reduced proliferative 
response of the PTK7  +   CD4  +   RTEs (unpublished data). 
  Because PTK7  +   CD4  +   RTEs are immediate peripheral 
descendants of thymocytes, we investigated whether they pos-
sessed any residual biological characteristics of thymocytes. 
Previous work has shown that IL-7, which plays a critical 
role in thymocyte development (  26  ), induces greater prolif-
eration of mature single-positive thymocytes than peripheral 
T cells (  27  ). Here, IL-7 treatment induced higher levels of 
proliferation of PTK7  +   CD4  +   RTEs compared with PTK7        
naive CD4  +   T cells (  Fig. 4 D  ). This greater proliferation to 
IL-7 was unlikely to be an artifact of PTK7 antibody staining, 
as neonatal naive CD4  +   T cells proliferated similarly to IL-7 
after staining with PTK7 antibody or isotype control antibody 
or no staining (  Fig. 4 E  ). These results are consistent with 
PTK7  +   CD4  +   RTEs having a thymocyte-like functional phe-
notype of increased IL-7 responsiveness. The mechanism for 
this increased IL-7 responsiveness remains unclear, but is not 
accounted for by higher surface levels of IL-7R     (  Fig. 2 C  ). 
  To determine whether decreased proliferation by PTK7  +   
CD4  +   RTEs refl  ected a generalized limitation in T cell 
the sjTREC content of PTK7  +  CD31  +   naive CD4  +   T cells 
was also substantially and consistently higher than that of 
PTK7       CD31  +   naive cells (  Fig. 3 B  ). For eight individuals 
ranging in age between 4 and 55 yr, the mean ratio   ±   SD of the 
sjTREC content of PTK7  +  CD31  +   cells to that of PTK7      
CD31  +   naive CD4  +   T cells was 2.66   ±   0.80, and this ratio 
did not signifi  cantly change with age (  Fig. 3 B  ). These fi  nd-
ings were consistent with PTK7 representing a marker for 
CD4  +   RTEs at all ages tested, and this consistency of higher 
sjTREC content in PTK7  +   naive CD4  +   T cells contrasts with 
the sjTREC content of CD31  +   naive CD4  +   T cells overall, 
which has been reported to decline with age (  23  ). This sug-
gests that PTK7  +   naive CD4  +   T cells, which are hereafter re-
ferred to as PTK7  +   CD4  +   RTEs, have undergone fewer cell 
divisions in the periphery than their PTK7        counterparts, in-
cluding CD31  +   naive CD4  +   T cells. Assuming that the PTK7  +   
CD4  +   RTEs are an obligatory precursor of PTK7        naive 
CD4  +   T cells, this indicates that normal postthymic CD4  +   
RTE maturation includes mitosis that, in contrast with CD31        
cells that have undergone homeostatic proliferation, main-
tains CD31 expression and a diverse         -TCR repertoire. 
  To confi  rm that PTK7  +   CD4  +   RTEs are recent and di-
rect products of the thymus, we examined the impact of 
complete thymectomy for the treatment of myasthenia gravis 
on this cell population. In a 2-yr-old and a 14-yr-old patient, 
there was a marked decline in both the frequency and circu-
lating numbers of PTK7  +   CD4  +   RTEs at 10 or 12 wk after 
surgery, respectively, and these remained low at the second 
postsurgical time point, 34 or 24 wk, respectively (  Fig. 3 C  ). 
Although the circulating numbers of both PTK7        and total 
naive CD4  +   T cells also declined at the fi  rst postthymectomy 
time point, these rebounded to near presurgical levels by the 
second postsurgical time point, whereas, in contrast, PTK7  +   
CD4  +   RTEs did not. Analysis of a healthy 5-yr-old individ-
ual showed that the PTK7  +   CD4  +   RTE population remained 
stable over a 12-wk period, indicating that the alterations ob-
served after thymectomy were not attributable to random bi-
ological variation (  Fig. 3 C  ). 
  Collectively, these fi  ndings are consistent with the fol-
lowing: (a) the direct and recent production of PTK7  +   CD4  +   
RTEs by the thymus; (b) an inability of extrathymic sources 
to replenish this cell population; and (c) a relatively short 
half-life of PTK7  +   CD4  +   RTEs as a result of either their con-
version to PTK7        naive CD4  +   T cells and/or their loss by 
cell death. The fraction of PTK7  +   CD4  +   RTEs that are con-
verted into PTK7        naive CD4  +   T cells versus those that die 
in the periphery while expressing surface PTK7 remains un-
certain. Future in vivo labeling studies might be informative 
in better quantifying the precursor  –  product relationship be-
tween circulating PTK7  +   CD4  +   RTEs and PTK7        naive 
CD4  +   T cells. 
  To determine if PTK7  +   CD4  +   RTEs can proliferate in an 
antigen-independent manner to become PTK7        naive CD4  +   
T cells, sorted PTK7  +   CD4  +   RTEs were CFSE labeled and 
cultured in vitro with a combination of cytokines to induce 
proliferation independent of         -TCR/CD3 engagement. JEM VOL. 206, February 16, 2009  281
BRIEF DEFINITIVE REPORT
    Figure 4.         Circulating PTK7  +   CD4  +   RTEs exhibit decreased proliferation after         -TCR and CD28 engagement and greater IL-7 responsiveness 
compared with PTK7        naive CD4  +   T cells.   (A)  [ 3  H]thymidine incorporation (mean   ±   SD of   n   = 4 donors) after culture with the indicated ratio of    -
CD3/    -CD28 beads/cell for 72 h (left) and for the indicated times with 0.3 beads/cell (right). *, P   <   0.01 by the two-tailed unpaired Student  ’  s   t   test. 
(B) CFSE mitosis assay and lymphocyte blastogenesis (forward vs. side scatter) after 48 and 72 h of stimulation with 0.1    -CD3/   -CD28 mAb beads/cell 
(representative results from one of fi  ve donors). (C) PTK7 antibody binding to neonatal naive CD4  +   T cells does not infl  uence their proliferative response to 
   -CD3/   -CD28 beads (representative results from one of three donors). (D) [  3  H]thymidine incorporation (mean   ±   SD of   n   = 3 donors) by PTK7  +   and  PTK7      
adult naive CD4  +   T cells after 5 d of culture in complete medium with or without 10 ng/ml of rhIL-7. *, P   <   0.001 by the two-tailed paired Student ’ s   t- test. 
(E) PTK7 antibody binding to neonatal naive CD4  +   T cells does not infl  uence their proliferative response to IL-7 (representative results from one of two 
donors). Error bars show the mean   ±   SD.     282 HUMAN CD4  +   RTES IDENTIFIED BY PTK7   | Haines et al. 
    Figure 5.         PTK7  +   CD4  +   RTEs exhibit a selective impairment of activation-induced function after engagement of the         -TCR/CD3 complex 
and CD28 compared with PTK7        naive CD4  +   T cells.   (A) Activation-dependent surface expression by PTK7  +   CD4 +   RTEs (dashed line) and PTK7        naive 
CD4  +   T cells (solid line) after stimulation with    -CD3/   -CD28 mAb beads for 12 (CD154) or 24 (CD25 and CD69) h (representative results from one of 
three donors). (B) Intracellular TNF-     and IL-2 expression after    -CD3/   -CD28 bead stimulation for 12 h (representative results from one of three do-
nors). (C) IL-2 content (mean   ±   SD of duplicate wells, with the results representative of one of four donors) in cell culture supernatants. (D) [  3 H]thymidine 
incorporation (mean   ±   SD) after culture with the indicated ratio of    -CD3/   -CD28 beads/cell for 96 h in the presence and absence of rhIL-2 (representa-
tive results from one of three donors). (E) IFN-     content (mean   ±   SD of   n   = 3 donors) in cell culture supernatants after Th1 differentiation for 72 h. *, P   <   
0.05 by the two-tailed unpaired Student  ’  s   t   test.   
activation, we compared this cell type and PTK7        naive 
CD4  +   T cells for surface expression of activation-dependent 
proteins and the production of cytokines. Activated PTK7  +   
CD4  +   RTEs expressed similar surface levels of CD25, CD69, 
and CD154 (  Fig. 5 A  ) and had similar frequencies of TNF-     
secreting cells as PTK7        naive CD4  +   T cells (  Fig. 5 B  ).   In 
contrast, IL-2 expression at the single cell level (  Fig. 5 B  ) and 
in terms of overall secretion (  Fig. 5 C  ) was markedly reduced 
for these cells compared with PTK7        naive CD4  +   T cells. 
Furthermore, the addition of exogenous recombinant IL-2 to JEM VOL. 206, February 16, 2009  283
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PTK7  +   CD4  +   RTEs completely increased their proliferation 
to levels comparable to those of PTK7        naive CD4  +   T cells, 
suggesting that RTEs have the capacity to fully respond to 
IL-2 stimulation but lack the ability to produce IL-2 in suffi   -
cient quantities for a full response (  Fig. 5 D  ). In contrast, both 
reduced IL-2 and IL-2 receptor expression may limit the ac-
tivation of mouse CD4  +   RTEs (  8  ). Activated PTK7  +   CD4  +   
RTEs also secreted markedly less IFN-     than PTK7        naive 
CD4  +   T cells using an in vitro assay for Th1 cell generation 
(  Fig. 5 E  ). These last fi  ndings suggest a mechanism for the 
observed vulnerability of the young infant to infections re-
quiring Th1 immunity for control, such as mycobacterial in-
fections, as PTK7  +   CD4  +   RTEs likely comprise a large fraction 
of the naive CD4  +   T cell compartment at this age (  9  ). 
  In contrast to humans, PTK7 was not expressed at detect-
able levels on mouse peripheral naive CD4  +   T cells at any 
postnatal age, indicating its lack of utility as a mouse RTE 
marker (unpublished data). Thus, despite the conserved pat-
tern of PTK7 expression in thymocytes, there may be substan-
tial species-related diff  erences in its peripheral T cell expression. 
Although PTK7 has been implicated in planar cell polarity 
during central nervous system embryonic development (  13  ), 
its function in T cell development remains unclear. 
  In summary, PTK7 is a novel marker for the measure-
ment of circulating human CD4  +   RTEs, which have im-
paired immune function compared with more mature naive 
CD4  +   T cells. The fi  ndings of a more pronounced and per-
sistent loss of PTK7  +   CD4  +   than PTK7       CD31  +   naive CD4  +   
T cells after complete thymectomy, and the higher sjTREC 
content of PTK7  +   CD4  +   compared with PTK7        naive CD4  +   
T cells, also suggest that PTK7 may identify RTEs that are 
more recently produced by the thymus than does CD31. Clin-
ical contexts in which measurement of thymic output based 
on PTK7 surface staining might be useful include treatment 
with cytotoxic agents, HIV infection, hematopoietic stem 
cell transplantation, and primary immunodefi  ciency (  5, 28, 29  ). 
Furthermore, the ability to isolate a circulating naive CD4  +   T 
cell population enriched for RTEs using PTK7 will allow 
better mechanistic studies of the function and phenotype of 
CD4  +   RTEs in health and disease. 
  MATERIALS AND METHODS 
  Cell sources and preparation.     Human thymus tissue was obtained from 
surgical pathology specimens of children undergoing cardiac surgery who 
did not have the 22q11.2 deletion syndrome. Human umbilical vein cord 
blood was obtained from the placentas of uncomplicated term pregnancies 
after routine Caesarian section delivery. Peripheral blood was obtained from 
healthy adult volunteer donors, children undergoing evaluation for immuno-
defi  ciency who had normal immune function tests, and two patients un-
dergoing complete thymectomy for the treatment of myasthenia gravis. All 
human samples were obtained with provision of informed consent and in a 
manner in accordance with approval by the Institutional Review Board of 
Stanford University. Circulating mononuclear cells were isolated from blood 
by Ficoll-Hypaque density gradient centrifugation. CD4  +   T cells were puri-
fi  ed from circulating mononuclear cells using a negative selection kit and a 
magnetic-activated cell sorting system (Miltenyi Biotec). Where indicated, 
CD4  +   T cells or thymocytes were stained for surface markers and subjected 
to purifi  cation by FACS. All mouse studies complied with federal guidelines 
and were approved by the Stanford University Administrative Panel on Lab-
oratory Care Committee. 
  PTK7-expressing CHO cells.     PCR was used for amplifi  cation and sub-
cloning of a human PTK7 cDNA (OriGene) into an hPTK7-pEGFP-N3 
construct. 10  6   CHO cells were transfected by electroporation with 20.0   μ  g 
of hPTK7-EGFP and analyzed by fl  ow cytometry 3 d later to verify EGFP 
fl  uorescence and PTK7 expression. 
  Cell surface staining with antibodies.     Cells were incubated at room 
temperature in PBS, pH 7.4, with 0.5% wt/vol BSA with fl  uorochrome-
conjugated mAbs for CD3, CD4, CD8, CD31, CD45RA, and CD45RO 
(Invitrogen or BD) or isotype-matched control mAbs of irrelevant specifi  city 
(Invitrogen). For surface PTK7 staining, cells were fi  rst sequentially incu-
bated with purifi  ed rabbit IgG (blocking step), affi   nity-purifi  ed rabbit IgG 
anti  –  mouse PTK7 (  13  ) or affi   nity-purifi  ed IgG from unimmunized rabbits 
(Invitrogen) for 20 min, and either FITC- or PE-conjugated F(ab    )  2   goat 
anti  –  rabbit IgG (Jackson ImmunoResearch Laboratories) for 20 min, with 
washing between each step. This was followed by the addition of the fl  uoro-
chrome-conjugated mAbs described at the beginning of this section. Cells 
were fi  xed for 5 min at room temperature in 2% paraformaldehyde except 
for experiments in which viable cells were purifi  ed using a FACS. Flow cy-
tometry was performed using a FACSCalibur instrument (BD). 
  Calculation of the circulating number of PTK7  +   naive CD4  +   T cells.   
  Absolute lymphocyte counts were obtained from contemporaneous com-
plete blood count data and were multiplied by the frequency of PTK7  +   naive 
(CD45RA  high  ) CD4  +   T cells among the lymphocytes of the blood sample, 
which were identifi  ed by forward-scatter versus side-scatter properties. 
  sjTREC content.     Total cellular DNA was isolated using a QIAamp DNA 
Mini kit (QIAGEN) and used in 20.0-  μ  l real-time PCR reactions in 384-
well plates analyzed in a 7900HT Fast Real Time PCR instrument (Applied 
Biosystems). Reactions included oligonucleotide primers and a TAMRA-
FAM labeled internal probe for the     Rec-    J     signal joint (  5  ). Internal stan-
dards that were cloned from human thymocyte DNA by PCR included a 
381-bp segment containing the     Rec-    J     signal joint (primers 5    -GAAAA-
CAGCCTTTGGGACAC-3     and 5   -GTGACATGGAGGGCTGAACT-3    , 
which were designed based on the homology of a rhesus macaque sjTREC 
sequence with human genomic sequences) and a 496-bp segment of the C     
region that is not aff  ected by V(D)J recombination (primers 5    -ATCAC-
GAGCAGCTGGTTTCT-3     and 5    -CCATTCCTGAAGCAAGGAAA-3    ). 
These products were used in standard curves ranging from 1.0   ×   10  1   to 
1.0   ×   10  5   copies per reaction. A TAMRA-FAM labeled internal probe 
for the C     region of the TCR-     gene locus was used for detection of C     
copy number (  5  ). 
  Real-time PCR.     Total cellular RNA was purifi  ed (Trizol; MRC) and 1.0 
  μ  g was reverse transcribed into cDNA using Superscript II enzyme (Invitro-
gen) and random hexamer primers. Real-time PCR was performed using 
SYBR Green (Roche) and primers 5    -CCACCTACCAATGGTTCCGA-3     
and 5    -TGCTCTGACCATCAGAAAGGG-3     (Primer Express software; 
Applied Biosystems) that amplify within exon 4 of PTK7, which is not sub-
ject to alternative RNA splicing (  11  ). Samples were normalized for total 
cDNA based on 18S rRNA levels (  30  ). Transcript levels were calculated us-
ing the double delta Ct equation (Applied Biosystems). 
  T cell proliferation and mitosis.     FACS-purifi  ed PTK7  +   and PTK7        naive 
(CD45RA  high  ) CD4  +   T cells were incubated in 200   μ  l of complete medium 
(RPMI 1640 with 10% heat-inactivated human AB serum, 50.0 U/ml penicil-
lin G, 50.0   μ  g/ml streptomycin, and 2.0 mM   l-  glutamine) in round-bottom 
96-well plates. For [  3  H]thymidine incorporation assays, cells were incubated in 
complete medium with or without     -CD3/    -CD28 mAb-coated paramag-
netic beads (Invitrogen) at concentrations of 0.1 and 0.3 beads/cell. Wells 
were pulsed with 1.0   μ  Ci [  3  H]thymidine during the fi  nal 16 h of culture, and 284 HUMAN CD4  +   RTES IDENTIFIED BY PTK7   | Haines et al. 
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cells were collected after 72 or 96 h of incubation using a cell harvester (Tomtec) 
and counted by liquid scintillation (Betaplate; PerkinElmer). In some experi-
ments, purifi  ed cells were cultured with 0.1 or 0.3     -CD3/    -CD28 beads/
cells with or without 100 U/ml of rhIL-2 (Proleukin) for 96 h, pulsed with 
[  3  H]thymidine, and assayed for tritium incorporation 18 h later. IL-7  –  depen-
dent proliferation was assessed by similar methods after purifi  ed cells were 
incubated with 10 ng/ml of recombinant human IL-7 (R  &  D Systems) or 
complete medium alone and harvested after 120 h of incubation. For mitotic 
analysis, cells were stained with 5.0   μ  M CFSE (Invitrogen) in 1 ml of 5% FCS 
in PBS for 5 min at room temperature, washed, and incubated with 0.1, 0.03, 
or 0.01     -CD3/    -CD28 beads/cell in complete medium. After 48 and 72 h, 
cells were collected and analyzed by fl  ow cytometry. 
  Intracellular cytokine staining.     Purifi  ed CD4  +   T     cell subsets were incu-
bated with 0.3     -CD3/    -CD28 beads/cell in complete medium for 12 h, 
with 10.0   μ  g/ml brefeldin A added during the last 3 h of culture. Cells were 
fi  xed, permeabilized, and stained for CD4 and intracellular IFN-     and TNF-     
(BD) and analyzed fl  ow cytometry. 
  Short-term Th1 cell generation for IFN-     content.     CD4  +   T cell sub-
sets were cultured at a 10:1 ratio with autologous CD14  +   monocytes and 0.3 
    -CD3/    -CD28 beads/T cell. Cell supernatants were collected after 72 h 
and IFN-     content was determined by ELISA (BD). 
  Online supplemental material.     Fig. S1 shows that PTK7 expression pro-
gressively decreases with mouse thymocyte maturation. Fig. S2 shows a de-
crease of the circulating concentration of PTK7  +   cells with aging. Fig. S3 
shows spectratyping of the TCR-     CDR3 region for three V     family mem-
bers, indicating that         -TCR repertoire for human PTK7  +   and PTK7        na-
ive CD4  +   T cells are similar and highly diverse. Fig. S4 shows a lack of PTK7 
expression by CD4  +  CD25  +  FoxP3  +   regulatory T cells. Fig. S5 shows a loss of 
surface expression of PTK7 but retention of CD31 with cytokine-mediated 
in vitro maturation. Supplemental materials and methods was used to gener-
ate the results of Figs. S1  –  S5. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20080996/DC1. 
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